The idea behind Ireland’s first Knowledge Transfer (KT) Offices, which will be in partnership with St. Vincent’s Healthcare Group (SVHG) and The Mater Misericordiae University Hospital (MMUH), was to develop the commercial potential of the research outputs emerging from both hospitals and to extend the reach of their medical advancements to a greater number of patients worldwide.
The KT Offices will be led by the guiding hand of Dr Ena Walsh (UCD’s life sciences knowledge transfer expert), with the aim of protecting the resulting intellectual property, assessing its commercial potential and, where appropriate, licensing this IP to life science companies or create new start-up companies to bring the innovations to market.
Tom Flanagan, Director of Enterprise and Commercialisation at UCD, commented: “The future of healthcare in Ireland is being shaped through research and innovation and both SVHG and the Mater have strong track records in the delivery of high quality research that provides meaningful impact to their patients. The Knowledge Transfer Offices will ensure that these innovations reach their full market potential and in doing so will increase access for more patients worldwide to new medical diagnostics and therapeutics”.
The KT Offices will accompany the ongoing quality health research that is rooted within several centres at both hospitals, including the UCD Clinical Research Centre (CRC) which sits across both the Mater and St. Vincent’s, the Education and Research Centre, at St. Vincent’s and the Clinical Trials Research Unit, at The Mater.
Clinicians can meet with Dr Walsh the first Wednesday of each month in SVUH and the first Friday of each month in the Mater.